Vivanza Biosciences Declares Unaudited Q1 FY27 Results

Vivanza Biosciences Ltd announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors convened on August 7, 2026, to review and approve these results, along with the accompanying Limited Review Report. The meeting also addressed disclosures of interest from Directors and confirmations of independence from Independent Directors as per relevant Companies Act and SEBI regulations. The financial results were prepared in accordance with Indian Accounting Standard 34 (Ind AS 34) for interim financial reporting.